The utility of novel outcome measures in a naturalistic evaluation of schizophrenia treatment.

about

The utility of novel outcome measures in a naturalistic evaluation of schizophrenia treatment.

Item

http://www.wikidata.org/entity/Q52657248

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The utility of novel outcome m ...... on of schizophrenia treatment.

@en

The utility of novel outcome m ...... on of schizophrenia treatment.

@nl

type

Item

label

The utility of novel outcome m ...... on of schizophrenia treatment.

@en

The utility of novel outcome m ...... on of schizophrenia treatment.

@nl

prefLabel

The utility of novel outcome m ...... on of schizophrenia treatment.

@en

The utility of novel outcome m ...... on of schizophrenia treatment.

@nl

P1476

The utility of novel outcome m ...... on of schizophrenia treatment.

@en

P2093

Kate Masters

http://www.w3.org/2001/XMLSchema#string

Tamara Tompsett

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial.

Long-acting paliperidone palmitate - interim results of an observational study of its effect on hospitalization.

Efficacy, safety, and impact on hospitalizations of paliperidone palmitate in recent-onset schizophrenia

A retrospective observational study of the effectiveness of paliperidone palmitate on acute inpatient hospitalization rates

Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics

Effectiveness of long-acting antipsychotics in clinical practice : 1. A retrospective, 18-month follow up and comparison between paliperidone palmitate, risperidone long-acting injection and zuclopenthixol decanoate

The relationship between patient satisfaction and treatment outcomes in schizophrenia.

A pragmatic analysis comparing once-monthly paliperidone palmitate versus daily oral antipsychotic treatment in patients with schizophrenia.

Real-world outcomes of paliperidone palmitate compared to daily oral antipsychotic therapy in schizophrenia: a randomized, open-label, review board-blinded 15-month study.

Design and rationale of the Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) study: a novel comparative trial of once-monthly paliperidone palmitate versus daily oral antipsychotic treatment for delaying time to treatment failu

P304

681-691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/NDT.S151174

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Parastou Donyai

P577

2018-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29535524

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

P932

5841343

http://www.w3.org/2001/XMLSchema#string